Before Invest
PFIZER INC logo

PFIZER INC

PFE
Pharmaceutical Preparations
Last filing · Quarter 2 · Jun 28, 2026
Financial Statements Ratios
Export XLSX
Unlock 14 years
Statement
Period
Annual Quarterly
Order
Format
% Change
Rows
USD ($)
$ in Millions, shares in Millions		LTMDec 31, 2025Dec 31, 2024Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019Dec 31, 2018Dec 31, 2017Dec 31, 2016Dec 31, 2015Dec 31, 2014Dec 31, 2013Dec 31, 2012Dec 31, 2011Dec 31, 2010Dec 31, 2009
Product revenues
-
-
-
$ 50,914
Alliance revenues
9,916
9,266
8,388
7,582
Total revenues
63,696
62,579
63,627
58,496
Costs and expenses:
                  
Cost of sales
17,083
16,067
17,851
24,954
Selling, informational and administrative expenses
13,720
13,794
14,730
14,771
Research and development expenses
11,051
10,437
10,822
10,679
Acquired in-process research and development expenses
1,755
1,613
108
194
Amortization of intangible assets
4,821
4,874
5,286
4,733
Acquisition-related in-process research and development charges
-
-
-
-
Restructuring charges and certain acquisition-related costs
1,447
1,550
2,419
2,943
(Gain) on completion of Consumer Healthcare JV transaction
-
-
-
-
Other (income)/deductions––net
(9,609)
(6,724)
(4,388)
835
Other deductions - net
-
-
-
-
Income from continuing operations before provision/(benefit) for taxes on income
4,209
7,520
8,023
1,058
Provision/(benefit) for taxes on income
(164)
(266)
(28)
(1,115)
Income from continuing operations
4,374
7,787
8,051
2,172
Discontinued operations:
                  
Income from discontinued operations––net of tax
-
-
-
-
Gain on disposal of discontinued operations––net of tax
-
-
-
-
Discontinued operations––net of tax
(5)
25
11
(15)
Net income before allocation to noncontrolling interests
4,369
7,812
8,062
2,158
Less: Net income attributable to noncontrolling interests
36
41
31
39
Net income attributable to Pfizer Inc. common shareholders
$ 4,334
$ 7,771
$ 8,031
$ 2,119
Earnings per common share––basic:
                  
Income from continuing operations attributable to Pfizer Inc. common shareholders (in dollars per share)
$ 0.77
$ 1.37
$ 1.42
$ 0.38
Discontinued operations––net of tax (in dollars per share)
0
0
0
0
Net income attributable to Pfizer Inc. common shareholders (in dollars per share)
0.77
1.37
1.42
0.38
Earnings per common share––diluted:
                  
Income from continuing operations attributable to Pfizer Inc. common shareholders (in dollars per share)
0.76
1.36
1.41
0.37
Discontinued operations––net of tax (in dollars per share)
0
0
0
0
Net income attributable to Pfizer Inc. common shareholders (in dollars per share)
0.76
1.36
1.41
0.37
Weighted-average shares––basic (in shares)
5,695
5,683
5,664
5,643
Weighted-average shares––diluted (in shares)
5,733
5,713
5,700
5,709
Cash dividends paid per common share (in dollars per share)
-
-
-
-